Next Article in Journal
Acknowledgement to Reviewers of Scientia Pharmaceutica in 2017
Previous Article in Journal
4,5-Dimethoxy-2-nitrobenzohydrazides and 1-(1-Benzylpiperidin-4-yl)ethan-1-ones as Potential Antioxidant/Cholinergic Endowed Small Molecule Leads
Article Menu

Export Article

Open AccessArticle

In Vitro Bioavailability Study of an Antiviral Compound Enisamium Iodide

Across Barriers, Science Park 1, 66123 Saarbruecken, Germany
Joint Stock Company Farmak, 63 Kyrylivska Street, 04080 Kiev, Ukraine
Dr. Regenold GmbH, Zoellinplatz 4, 79410 Badenweiler, Germany
Authors to whom correspondence should be addressed.
Sci. Pharm. 2018, 86(1), 3;
Received: 11 October 2017 / Revised: 5 January 2018 / Accepted: 8 January 2018 / Published: 11 January 2018
PDF [1689 KB, uploaded 11 January 2018]


An investigation into the biopharmaceutics classification and a study of the in vitro bioavailability (permeability and solubility) of the antiviral compound enisamium iodide (4-(benzylcarbamoyl)-1-methylpyridinium iodide) were carried out. The solubility of enisamium iodide was determined in four different buffers. Apparent intestinal permeability (Papp) of enisamium iodide was assessed using human colon carcinoma (Caco-2) cells at three concentrations. The solubility of enisamium iodide in four buffer solutions from pH 1.2 to 7.5 is about 60 mg/mL at 25 °C, and ranges from 130 to 150 mg/mL at 37 °C, depending on the pH. Based on these results, enisamium iodide can be classified as highly soluble. Enisamium iodide demonstrated low permeability in Caco-2 experiments in all tested concentrations of 10–100 μM with permeability coefficients between 0.2 × 10−6 cm s−1 and 0.3 × 10−6 cm s−1. These results indicate that enisamium iodide belongs to class III of the Biopharmaceutics Classification System (BCS) due to its high solubility and low permeability. The bioavailability of enisamium iodide needs to be confirmed in animal and human studies. View Full-Text
Keywords: bioavailability; biopharmaceutics classification system; permeability; solubility bioavailability; biopharmaceutics classification system; permeability; solubility

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Haltner-Ukomadu, E.; Gureyeva, S.; Burmaka, O.; Goy, A.; Mueller, L.; Kostyuk, G.; Margitich, V. In Vitro Bioavailability Study of an Antiviral Compound Enisamium Iodide. Sci. Pharm. 2018, 86, 3.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics



[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top